Company research / CWLXF

C21 Investments Inc. (CWLXF)

CIK 0000831609 · OTC · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Fiscal year ends around Mar 31

For the year ended 2026-03-31, C21 Investments Inc. reported revenue of $32.61M. Revenue grew 8.3% from the prior annual period.

Key ratios (year ended 2026-03-31)

41.7%
Gross margin
7.0%
Operating margin
-9.9%
Net margin
-12.8%
Return on year-end equity
8.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-08-21

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.